Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.

B A Arana Center for Health Studies, Universidad del Valle de Guatemala, Guatemala. baaz@cdc.gov

Search for other papers by B A Arana in
Current site
Google Scholar
PubMed Close
,
C E Mendoza Center for Health Studies, Universidad del Valle de Guatemala, Guatemala. baaz@cdc.gov

Search for other papers by C E Mendoza in
Current site
Google Scholar
PubMed Close
,
N R Rizzo Center for Health Studies, Universidad del Valle de Guatemala, Guatemala. baaz@cdc.gov

Search for other papers by N R Rizzo in
Current site
Google Scholar
PubMed Close
, and
A Kroeger Center for Health Studies, Universidad del Valle de Guatemala, Guatemala. baaz@cdc.gov

Search for other papers by A Kroeger in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.2001.65.466
Volume/Issue:
Volume 65: Issue 5
Page(s):
466–470
Restricted access
Get Permissions

A double-blind, randomized trial was undertaken in Guatemala to determine the therapeutic efficacy of an ointment for the treatment of cutaneous leishmaniasis that contained 15% paromomycin and 12% methylbenzethonium chloride and that was applied twice a day for 20 days. The treatment group included 35 patients, and the placebo group included 33 patients. The initial clinical response rate (13 weeks after completing the treatment) was 91.4% in the treatment group and 39.4% in the placebo group. The final clinical response rate at the 12-month follow-up examination was 85.7% (31 of 35) in the treatment group and 39.4% (13 of 33) in the placebo group (P < or = 0.001). In general, the treatment was well tolerated and was never interrupted because of adverse effects. The number of adverse effects reported in the placebo group was lower than in the treatment group (16 events versus 30 events). All adverse effects reported by patients disappeared within 1 week of completing the treatment. Our findings show that the combination of paromomycin with methylbenzethonium chloride for 20 days is a good alternative for antimonial treatments of cutaneous leishmaniasis in Guatemala.

Published Online:
Nov 2001
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 34 34 9
Full Text Views 443 110 1
PDF Downloads 90 30 0
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save